Clinical Trials for Acute Myelogenous Leukemia

Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

NCT ID: NCT03971799

This clinical trial is studying a new treatment called CD33CAR T-cell therapy for children and young adults with a type of blood cancer known as acute myeloid leukemia (AML) that has come back or h...

Biology Studies of Hematologic Cancers

NCT ID: NCT00923442

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

NCT ID: NCT06904482

This clinical trial is looking to find out if combining two types of stem cell donors—one from a family member and one from umbilical cord blood—can help people with certain blood cancers live long...

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

NCT ID: NCT06680661

The ABBA CORD clinical trial is designed to test whether adding a medication called abatacept to standard treatments can help prevent a serious complication known as acute graft versus host disease...

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT ID: NCT01890486

This clinical trial is focused on collecting and reporting information about patients who are receiving hematopoietic stem cell transplants, which are treatments often used for certain types of blo...

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT ID: NCT05805605

This clinical trial is looking at a new approach to treating certain blood cancers, including various types of leukemia and lymphoma. The study is specifically evaluating a method called "Allo HSCT...

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT ID: NCT06131801

This clinical trial is studying how well venetoclax, a medication used to treat certain types of blood cancers like leukemia and lymphoma, works when the tablets are crushed and dissolved in liquid...

ICP-248 in Combination with Azacitidine in Treatment-Naïve Subjects with Acute Myelogenous Leukemia(AML) or Previously Treated Relapsed/Refractory Subjects with Acute Myelogenous Leukemia(R/R AML).

NCT ID: NCT06656494

This clinical trial is studying the combination of two treatments, ICP-248 and azacitidine, for patients with Acute Myelogenous Leukemia (AML). AML is a type of cancer that affects the blood and bo...

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

NCT ID: NCT05974150

This clinical trial is focused on understanding the experiences of patients with breast cancer, lung cancer, ovarian cancer, multiple myeloma, or acute myelogenous leukemia while they are receiving...

Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients

NCT ID: NCT03679650

This clinical trial is investigating a new cancer vaccine called the Dendritic Cell/AML Fusion vaccine (DC/AML vaccine) to see if it can help patients with Acute Myelogenous Leukemia (AML) after th...

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT ID: NCT04278768

This clinical trial is studying a new medication called emavusertib (CA-4948) for patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS). The trial is divided into two par...

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT ID: NCT04904588

This clinical trial is exploring a new approach to treating certain blood cancers, including types of leukemia and lymphoma, through a procedure called hematopoietic cell transplantation (HCT). In ...

Role of BMP Pathway in MDS Progression

NCT ID: NCT06175923

This clinical trial is investigating the role of a specific biological pathway called the Bone Morphogenetic Protein (BMP) pathway in the progression of myelodysplastic syndromes (MDS), which are b...

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

NCT ID: NCT05974137

This clinical trial is looking at how patients with breast cancer, lung cancer, ovarian cancer, multiple myeloma, or acute myelogenous leukemia are managing their symptoms while receiving treatment...